Thiazolidinedione therapy for nonalcoholic steatohepatitis: go, stop, or proceed with caution?

Hepatology. 2010 Feb;51(2):366-9. doi: 10.1002/hep.23473.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fatty Liver / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Thiazolidinediones / administration & dosage*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • 2,4-thiazolidinedione